Artificial Intelligence to Optimize Early-stage Hepatocellular CarcinomaTreatment Based on Multi-modal Image

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Observational
SUMMARY

This study intends to establish two prognostic models based on contrast-enhanced ultrasound (CEUS) and dynamic enhanced magnetic resonance (DE-MRI) multimodal images: prognostic model of liver cancer patients after hepatectomy and prognostic model of liver cancer patients after radiofrequency ablation. Combined with artificial intelligence imaging omics, traditional imaging omics and clinical information, to predict and compare the prognosis of two different treatment methods for early liver cancer, so as to realize the individual selection of treatment methods for early liver cancer patients

Eligibility
Participation Requirements
Sex: All
Healthy Volunteers: f
View:

• Primary single hepatocellular carcinoma confirmed by histology or cytology, with a maximum diameter ≤5.0 cm;

⁃ Good liver function, Child-Pugh grade A;

‣ No serious dysfunction of heart, lung, kidney and other important organs ④ Liver resection or radiofrequency ablation was performed in our hospital, and the study protocol and follow-up procedure were followed.

Locations
Other Locations
China
Nanjing Drum Tower Hospital
RECRUITING
Nanjing
Contact Information
Primary
Wentao Kong
breezewen@163.com
13815897824
Backup
Han Liu
liuhanDEonly@163.com
13058328870
Time Frame
Start Date: 2022-12-01
Estimated Completion Date: 2025-11-01
Participants
Target number of participants: 200
Treatments
SR
RFA
Related Therapeutic Areas
Sponsors
Leads: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

This content was sourced from clinicaltrials.gov